The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Precision Medicine Diagnostics Market Research Report 2025
Synopsis
Precision medicine aims to alter the treatments based on individual characteristics, including differences in genetics, environment, and lifestyle. It has the potential to transform the delivery of care for a variety of diseases.
The global Precision Medicine Diagnostics market was valued at US$ 79760 million in 2023 and is anticipated to reach US$ 106650 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Precision Medicine Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine Diagnostics.
Report Scope
The Precision Medicine Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Medicine Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Medicine Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Intomics
Ferrer Incode
Nanostring Technologies
Tepnel Pharma Services
Pfizer
Novartis
Teva Pharmaceuticals
Merck & Co.
Qiagen
Quest Diagnostics
Segment by Type
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
Segment by Application
Oncology
CNS
Hematology
Respiratory
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Medicine Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Precision medicine aims to alter the treatments based on individual characteristics, including differences in genetics, environment, and lifestyle. It has the potential to transform the delivery of care for a variety of diseases.
The global Precision Medicine Diagnostics market was valued at US$ 79760 million in 2023 and is anticipated to reach US$ 106650 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Precision Medicine Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Medicine Diagnostics.
Report Scope
The Precision Medicine Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Medicine Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Medicine Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Intomics
Ferrer Incode
Nanostring Technologies
Tepnel Pharma Services
Pfizer
Novartis
Teva Pharmaceuticals
Merck & Co.
Qiagen
Quest Diagnostics
Segment by Type
Bioinformatics
Gene Sequencing
Drug Discovery
Precision Molecular Diagnostics
Big Data Analytics
Segment by Application
Oncology
CNS
Hematology
Respiratory
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Medicine Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Medicine Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bioinformatics
1.2.3 Gene Sequencing
1.2.4 Drug Discovery
1.2.5 Precision Molecular Diagnostics
1.2.6 Big Data Analytics
1.3 Market by Application
1.3.1 Global Precision Medicine Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 CNS
1.3.4 Hematology
1.3.5 Respiratory
1.3.6 Immunology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Medicine Diagnostics Market Perspective (2019-2030)
2.2 Precision Medicine Diagnostics Growth Trends by Region
2.2.1 Global Precision Medicine Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Precision Medicine Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Precision Medicine Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Precision Medicine Diagnostics Market Dynamics
2.3.1 Precision Medicine Diagnostics Industry Trends
2.3.2 Precision Medicine Diagnostics Market Drivers
2.3.3 Precision Medicine Diagnostics Market Challenges
2.3.4 Precision Medicine Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Medicine Diagnostics Players by Revenue
3.1.1 Global Top Precision Medicine Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Precision Medicine Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Precision Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Medicine Diagnostics Revenue
3.4 Global Precision Medicine Diagnostics Market Concentration Ratio
3.4.1 Global Precision Medicine Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Medicine Diagnostics Revenue in 2023
3.5 Precision Medicine Diagnostics Key Players Head office and Area Served
3.6 Key Players Precision Medicine Diagnostics Product Solution and Service
3.7 Date of Enter into Precision Medicine Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Medicine Diagnostics Breakdown Data by Type
4.1 Global Precision Medicine Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Precision Medicine Diagnostics Forecasted Market Size by Type (2025-2030)
5 Precision Medicine Diagnostics Breakdown Data by Application
5.1 Global Precision Medicine Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Precision Medicine Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Precision Medicine Diagnostics Market Size (2019-2030)
6.2 North America Precision Medicine Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Precision Medicine Diagnostics Market Size by Country (2019-2024)
6.4 North America Precision Medicine Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Medicine Diagnostics Market Size (2019-2030)
7.2 Europe Precision Medicine Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Precision Medicine Diagnostics Market Size by Country (2019-2024)
7.4 Europe Precision Medicine Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Medicine Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Precision Medicine Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Precision Medicine Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Precision Medicine Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Medicine Diagnostics Market Size (2019-2030)
9.2 Latin America Precision Medicine Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Precision Medicine Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Precision Medicine Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Medicine Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Precision Medicine Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Precision Medicine Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Precision Medicine Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intomics
11.1.1 Intomics Company Detail
11.1.2 Intomics Business Overview
11.1.3 Intomics Precision Medicine Diagnostics Introduction
11.1.4 Intomics Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.1.5 Intomics Recent Development
11.2 Ferrer Incode
11.2.1 Ferrer Incode Company Detail
11.2.2 Ferrer Incode Business Overview
11.2.3 Ferrer Incode Precision Medicine Diagnostics Introduction
11.2.4 Ferrer Incode Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.2.5 Ferrer Incode Recent Development
11.3 Nanostring Technologies
11.3.1 Nanostring Technologies Company Detail
11.3.2 Nanostring Technologies Business Overview
11.3.3 Nanostring Technologies Precision Medicine Diagnostics Introduction
11.3.4 Nanostring Technologies Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.3.5 Nanostring Technologies Recent Development
11.4 Tepnel Pharma Services
11.4.1 Tepnel Pharma Services Company Detail
11.4.2 Tepnel Pharma Services Business Overview
11.4.3 Tepnel Pharma Services Precision Medicine Diagnostics Introduction
11.4.4 Tepnel Pharma Services Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.4.5 Tepnel Pharma Services Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Precision Medicine Diagnostics Introduction
11.5.4 Pfizer Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Precision Medicine Diagnostics Introduction
11.6.4 Novartis Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Detail
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Precision Medicine Diagnostics Introduction
11.7.4 Teva Pharmaceuticals Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Merck & Co.
11.8.1 Merck & Co. Company Detail
11.8.2 Merck & Co. Business Overview
11.8.3 Merck & Co. Precision Medicine Diagnostics Introduction
11.8.4 Merck & Co. Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.8.5 Merck & Co. Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Detail
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Precision Medicine Diagnostics Introduction
11.9.4 Qiagen Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.9.5 Qiagen Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Detail
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Precision Medicine Diagnostics Introduction
11.10.4 Quest Diagnostics Revenue in Precision Medicine Diagnostics Business (2019-2024)
11.10.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
